Free Trial

Transcat, Inc. (NASDAQ:TRNS) Receives Consensus Recommendation of "Hold" from Analysts

Transcat logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Consensus "Hold": Five brokerages give Transcat an average rating of "Hold" (two sell, two buy, one strong buy) with a mean 12‑month target of $105.33.
  • Mixed quarterly results: Transcat reported Q results showing an EPS miss ($0.26 vs. $0.30 consensus) but revenue beat ($83.86M vs. $80.99M), and analysts forecast ~1.83 EPS for the fiscal year.
  • High institutional ownership: Institutional investors own about 98.34% of the stock, with large recent stake increases from firms including Wellington, First Eagle, Renaissance and Royce.
  • Interested in Transcat? Here are five stocks we like better.

Transcat, Inc. (NASDAQ:TRNS - Get Free Report) has been given an average recommendation of "Hold" by the five brokerages that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, two have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $105.3333.

Separately, Zacks Research lowered shares of Transcat from a "hold" rating to a "strong sell" rating in a research note on Monday, April 6th.

Check Out Our Latest Stock Analysis on TRNS

Transcat Price Performance

Shares of TRNS opened at $75.33 on Wednesday. The business's 50-day moving average is $76.20 and its 200-day moving average is $67.70. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.21 and a quick ratio of 1.85. The company has a market capitalization of $702.83 million, a price-to-earnings ratio of 88.62 and a beta of 0.68. Transcat has a fifty-two week low of $50.23 and a fifty-two week high of $97.08.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 EPS for the quarter, missing the consensus estimate of $0.30 by ($0.04). The company had revenue of $83.86 million for the quarter, compared to analyst estimates of $80.99 million. Transcat had a return on equity of 6.15% and a net margin of 2.47%. Equities research analysts expect that Transcat will post 1.83 EPS for the current fiscal year.

Institutional Trading of Transcat

Institutional investors have recently bought and sold shares of the company. Wellington Management Group LLP grew its stake in Transcat by 677.7% in the fourth quarter. Wellington Management Group LLP now owns 248,539 shares of the scientific and technical instruments company's stock valued at $14,100,000 after purchasing an additional 216,579 shares in the last quarter. First Eagle Investment Management LLC acquired a new stake in shares of Transcat during the 4th quarter valued at about $7,259,000. King Luther Capital Management Corp grew its stake in shares of Transcat by 182.3% in the 4th quarter. King Luther Capital Management Corp now owns 103,750 shares of the scientific and technical instruments company's stock valued at $5,886,000 after buying an additional 67,000 shares in the last quarter. Royce & Associates LP grew its stake in shares of Transcat by 15.3% in the 4th quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company's stock valued at $22,156,000 after buying an additional 51,774 shares in the last quarter. Finally, Renaissance Technologies LLC increased its holdings in Transcat by 109.7% in the fourth quarter. Renaissance Technologies LLC now owns 95,200 shares of the scientific and technical instruments company's stock worth $5,401,000 after buying an additional 49,800 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.

About Transcat

(Get Free Report)

Transcat, Inc NASDAQ: TRNS is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.

Featured Stories

Analyst Recommendations for Transcat (NASDAQ:TRNS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Transcat Right Now?

Before you consider Transcat, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.

While Transcat currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines